SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-22-003161
Filing Date
2022-06-03
Accepted
2022-06-03 10:54:55
Documents
1
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4519
  Complete submission text file 0000902664-22-003161.txt   6766
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Reporting) CIK: 0001410830 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39263 | Film No.: 22993272

Mailing Address C/O MATRIX CAPITAL MANAGEMENT CO., LP 1000 WINTER STREET, SUITE 4500 WALTHAM MA 02451
Business Address
GOEL DAVID E. (Reporting) CIK: 0001548144 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39263 | Film No.: 22993271

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations